Arthur David J.
SEC CIK 1769331 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DCOY | Decoy Therapeutics Inc. | CEO, Dir | 48.0K | $65.9K | — | 11 | 2021-08-17 | 2023-02-13 |
Most active insiders at DCOY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rosenblum Mark J | CFO, EVP Fin | $16.0K | — |
| 2 | HANISH ARNOLD C | Dir | $3,750 | $17.28 |
| 3 | Gauthier Patricia G. | Dir | — | — |
| 4 | Marschel Peter Klaus | Chief Business Off | — | — |
| 5 | Hibner Barbara Louise | CSO | — | — |
| 6 | Burleson Tess | Dir | — | — |
| 7 | McVicar William K. | Dir | — | — |
| 8 | Lammers Paul | Dir | — | — |
| 9 | Lieber Jonathan I | Dir | — | — |
| 10 | PIERCE FREDERICK II | CEO | — | — |
Arthur David J. made no open-market trades at DCOY in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-15 | 2023-02-13 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $0.00 | +14.3K | 48.0K | +42% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $0.00 | +20.0K | 33.7K | +146% | $0 | |
| A | 2022-12-12 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +2,693 | 13.7K | +24% | +$4,659 |
| A | 2022-11-08 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +10.0K | 21.0K | +91% | +$17.3K |
| 2022-11-07 | 2022-11-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +10.0K | 285.7K | +4% | +$17.3K | |
| MI | 2022-05-31 | 2022-05-26 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | P - Purchase | $0.18 | +21.9K | 282.4K | +8% | +$3,942 |
| M | 2022-05-31 | 2022-05-26 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | P - Purchase | $0.18 | +22.0K | 281.7K | +8% | +$3,960 |
| 2022-05-05 | 2022-05-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $0.19 | +10.0K | 259.7K | +4% | +$1,900 | |
| 2022-03-09 | 2022-03-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | P - Purchase | $0.39 | +139.5K | 249.7K | +127% | +$54.4K | |
| 2021-11-05 | 2021-11-03 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | A - Grant | $0.72 | +7,939 | 110.2K | +8% | +$5,716 | |
| MI | 2021-08-17 | 2021-08-17 | DCOY | Decoy Therapeutics Inc. | Arthur David J. | CEO, Dir | P - Purchase | $0.895 | +4,000 | 102.2K | +4% | +$3,580 |
Purchase Sale Sale after option exercise All abbreviations